Subscribe to RSS
DOI: 10.1055/s-0029-1219208
Progress towards the Total Synthesis of Scytonemin A: Asymmetric Synthesis of (2S,3R,4R)-4-hydroxy-3-methylproline
Publication History
Publication Date:
19 January 2010 (online)

Abstract
During the total synthesis of the novel cyclopeptide scytonemin A, the fragment containing two (2S,3R,4R)-4-hydroxy-3-methylproline units was successfully prepared. Two approaches leading to (2S,3R,4R)-4-hydroxy-3-methylproline have been explored. They involve the following key transformations: asymmetric crotylation, Sharpless epoxidation-subsequent epoxide opening, intramolecular amidomercuration-oxidation.
Key words
scytonemin A - cyclopeptide - substituted proline - amino acids - asymmetric synthesis
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Ebel R. In Frontiers in Marine BiotechnologyProksch P.Muller WEG. Horizon Bioscience; England: 2006. p.73-144 -
1b
Ramaswamy AV.Flatt PM.Edwards DJ.Simmons TL.Han B.Gerwick WH. In Frontiers in Marine BiotechnologyProksch P.Muller WEG. Horizon Bioscience; England: 2006. p.175-224 -
1c
Drugs
from the Sea
Fusetani N. S. Karger AG; Basel: 2000. -
1d
Fusetani N.Matsunaga S. Chem. Rev. 1993, 93: 1793 -
1e
Davidson BS. Chem. Rev. 1993, 93: 1771 -
2a
Proksch P.Edrada R.Lin WH. In Frontiers in Marine BiotechnologyProksch P.Muller WEG. Horizon Bioscience; England: 2006. p.1-20 -
2b
Newman DJ.Gragg GM. J. Nat. Prod. 2004, 67: 1216 -
2c
Proksch P.Edrada RA.Ebel R. Appl. Microbiol. Biotechnol. 2002, 59: 125 -
2d
Frenz JL.Kohl AC.Kerr RG. Expert Opin. Ther. Pat. 2004, 14: 17 -
2e
Wipf P. Chem. Rev. 1995, 95: 2115 - 3
Helms GL.Moore RE.Niemczura WP.Patterson GML. J. Org. Chem. 1988, 53: 1298 -
4a
Liang S.Xu Z.Ye T. Chem. Commun. 2010, 46: in press; DOI: 10.1039/b921000h -
4b
Li S.Liang S.Tan WF.Xu ZS.Ye T. Tetrahedron 2009, 65: 2695 -
4c
Ren Q.Dai L.Zhang H.Tan WF.Xu ZS.Ye T. Synlett 2008, 2379 -
4d
Li S.Liang S.Xu ZS.Ye T. Synlett 2008, 569 -
4e
Chen Z.Ye T. New J. Chem. 2006, 30: 518 -
4f
Pang HW.Xu ZS.Chen ZY.Ye T. Lett. Org. Chem. 2005, 2: 699 -
4g
Peng YG.Pang HW.Xu ZS.Ye T. Lett. Org. Chem. 2005, 2: 703 -
4h
Xu ZS.Ye T. Tetrahedron: Asymmetry 2005, 16: 1905 -
4i
Chen HL.Xu ZS.Ye T. Tetrahedron 2005, 61: 11132 -
4j
Chen ZY.Ye T. Synlett 2005, 2781 -
4k
Xu ZS.Chen Z.Ye T. Tetrahedron: Asymmetry 2004, 15: 355 -
4l
Peng YG.Pang HW.Ye T. Org. Lett. 2004, 6: 3781 -
4m
Chen ZY.Deng JGYeT. ARKIVOC 2003, (vii): 268 -
4n
Xu ZS.Peng YG.Ye T. Org. Lett. 2003, 5: 2821 - For the synthesis of racemic and enantiomerically enriched 4-hydroxy-3-methylproline, please see:
-
5a
Anderson JC.Flaherty A. J. Chem. Soc., Perkin Trans. 1 2001, 267 -
5b
Anderson JC.O’Loughlina JMA.Tornos JA. Org. Biomol. Chem. 2005, 3: 2741 -
6a
Brown HC.Bhat KS. J. Am. Chem. Soc. 1986, 108: 293 -
6b
Brown HC.Bhat KS.Randad RS. J. Org. Chem. 1989, 54: 1570 -
7a
Harding KE.Burks SR. J. Org. Chem. 1981, 46: 3920 -
7b
Harding KE.Burks SR. J. Org. Chem. 1984, 49: 40 -
7c
Harding KE.Marman TH. J. Org. Chem. 1984, 49: 2838 -
7d
Kinsman R.Lathbury D.Vernon P.Gallagher T. J. Chem. Soc., Chem. Commun. 1987, 243 -
7e
Tokuda M.Yamada Y.Suginome H. Chem. Lett. 1988, 17: 1289 -
7f
Takahata H.Takehara H.Ohkubo N.Momose T. Tetrahedron: Asymmetry 1990, 1: 561 -
7g
Takahata H.Bandoh H.Momose T. Tetrahedron: Asymmetry 1991, 2: 351 -
7h
Singh S.Chikkanna D.Singh OV.Han H. Synlett 2003, 1279 -
7i
Khalaf JK.Datta A. J. Org. Chem. 2004, 69: 387 -
7j
Chikkanna D.Han H. Synlett 2004, 2311 -
8a
Katsuki T.Sharpless KB. J. Am. Chem. Soc. 1980, 102: 5974 -
8b
Gao Y.Hanson RM.Klunder JM.Ko SY.Masamune H.Sharpless KB. J. Am. Chem. Soc. 1987, 109: 5765 -
9a
Markad SD.Karanjule NS.Sharma T.Sabharwal SG.Puranik VG.Dhavale DD. Org. Biomol. Chem. 2006, 4: 2549 -
9b
Benedetti F.Berti F.Dinon F.Nardin G.Norbedo S. Org. Lett. 2004, 6: 1017 -
9c
Saotome C.Kanie Y.Kanie O.Wong C.-H. Bioorg. Med. Chem. 2000, 8: 2249 -
9d
Beier C.Schaumann E. Synthesis 1997, 1296 -
9e
Gleave DM.Brickner SJ. J. Org. Chem. 1996, 61: 6470 -
9f
Kim NS.Choi JR.Cha JK. J. Org. Chem. 1993, 58: 7096 -
9g
Carpenter NM.Fleet GWJ.Di Bello IC.Winchester B.Fellows LE.Nash RJ. Tetrahedron Lett. 1989, 30: 7261 - 10
De Luca L.Giacomelli G.Porcheddu A. Org. Lett. 2001, 3: 3041 - 11
Yu W.Mei Y.Kang Y.Hua Z.Jin Z. Org. Lett. 2004, 6: 3217 - 13
Bal BS.Childers WE.Pinnick HW. Tetrahedron 1981, 37: 2091 - 14
Sarraf ST.Leighton JL. Org. Lett. 2000, 2: 403
References and Notes
Procedure for
the Synthesis of 4 via Epoxide Opening
Epoxide 5 (0.65 g, 1.6 mmol) was dissolved in MeOH
(10 mL). After a catalytic amount of Pd/C (10%)
was added, the reaction was exposed to an atmosphere of H2 at
ambient temperature. The reaction was monitored by TLC. After all starting
material was consumed (ca. 2 h), the reaction mixture was stirred
for an additional 1 h and then filtered through a pad of Celite.
The filter cake was washed with MeOH (10 mL). The combined filtrate
and washings were concentrated in vacuo to leave the corresponding
amine as an oil, which was dissolved in THF-H2O
(20 mL, 1:1) at 0 ˚C and treated with NaHCO3 (0.25
g, 3.0 mmol) and CbzCl (0.29 mL, 2.0 mmol). The reaction mixture
was stirred at r.t. for 3 h and then concentrated in vacuo. The
residue was extracted with EtOAc (3 × 20
mL). The combined organic phases were washed with brine (30 mL),
dried over anhydrous Na2SO4, and concentrated
in vacuo. The residue was purified by flash chromatography on silica
gel, eluting with EtOAc-hexane (2:3) to give desired product 4 (0.49 g, 75%); [a]D
²5 -6.6
(c 0.70, CHCl3). ¹H
NMR (500 MHz, CDCl3): δ = 7.40-7.29
(m, 5 H), 5.17 (s, 2 H), 4.17 (d, J = 3.3
Hz, 1 H), 4.11 (d, J = 9.0
Hz, 1 H), 3.73 (dd, J = 4.2, 7.1
Hz, 1 H), 3.61-3.58 (m, 4 H), 3.34 (dd, J = 4.1,
11.6 Hz, 1 H), 3.09-3.07 (m, 1 H), 2.18 (dd, J = 6.9, 11.5
Hz, 1 H), 1.12 (d, J = 6.9
Hz, 3 H), 0.88 (s, 9 H), 0.07 (s, 3 H), 0.04 (s, 3 H). ¹³C
NMR (125 MHz, CDCl3): δ = 157.7, 136.3, 128.5 (128.5),
128.2, 128.0 (127.9), 73.4, 72.2, 67.6, 65.7, 62.9, 54.5, 41.4,
25.8 (25.7), 18.0, 13.0, -4.9, -5.0 ppm. ESI-HRMS: m/z calcd for C21H36NO5Si+ [M + H]+:
410.2351; found: 410.2375.
Procedure for
the Synthesis of 11 via Amidomercuration-Oxidation
To
a stirred solution of compound 8 (0.88
g, 2.40 mmol) in MeCN (20 mL), Hg(OAc)2 (2.26 g, 7.20
mmol) was added. The reaction mixture was refluxed for 2 h and then
cooled to r.t. EtOAc (10 mL) and brine (10 mL) were added, and the mixture
was stirred at r.t. for a further 1.5 h and filtered to remove the
precipitated inorganic byproduct. The filtrate was separated and
the aqueous layer was extracted with EtOAc (3 × 50
mL). The combined organic phases were dried over anhydrous Na2SO4 and
concentrated in vacuo to give 7 as a colorless
foam. In a second reaction vessel, oxygen (O2) was bubbled
into a well-stirred solution of NaBH4 (0.09 g, 2.4 mmol)
in DMF (25 mL) at r.t. One hour later, the above intermediate in
DMF (25 mL) was slowly added over 2 h, while maintaining the flow
of oxygen. Upon completion of addition, the reaction mixture was
stirred for additional 2 h and then filtered through a pad of Celite, eluting
thoroughly with EtOAc (200 mL). The filtrate was concentrated in
vacuo, and the residue was purified by flash chromatography (EtOAc-hexane, 3:1)
to afford the diastereoisomers 11α (0.23
g, 26%) and 11β (0.22
g, 24%).
Analytical Data for
11α
[α]D
²5 +28.6
(c 0.54, CHCl3). ¹H
NMR (500 MHz, CDCl3); δ = 7.37-7.27
(m, 5 H), 5.22-5.09 (m, 2 H), 4.24-4.02 (m, 2 H),
3.94-3.79 (m, 2 H), 3.72-3.66 (m, 1 H), 3.60-3.55
(m, 1 H), 3.52-3.42 (m, 1 H), 2.46-2.33 (m, 1
H), 1.07 (1.05) (d, J = 7.4
Hz, 3 H), 0.92 (0.91) (s, 9 H), 0.14 (0.09) (s, 6 H) ppm. ¹³C
NMR (125 MHz, CDCl3): δ = 156.1 (154.9),
136.7, 128.5, 128.0, 127.9, 73.4 (72.8), 67.1, 62.8 (61.9), 61.5 (59.8),
56.1 (55.4), 41.4 (40.7), 25.7, 18.0, 9.9 (9.7), -4.8,
-5.1
ppm. ESI-HRMS: m/z calcd for
C20H34NO4Si+ [M + H]+:
380.2252; found: 380.2268.
Analytical
Data for 11β
[α]D
²5 -2.0
(c 0.16, CHCl3). ¹H
NMR (500 MHz, CDCl3):
δ = 7.38-7.33
(m, 5 H), 5.35-5.10 (m, 2 H), 4.85 (br, 1 H) 4.05 (br,
1 H), 3.82-3.80 (m, 1 H), 3.70-3.66 (m, 1 H),
3.62-3.58 (m, 2 H), 3.38 (dd, J = 3.0,
13.4 Hz, 1 H), 1.84-1.77 (m, 1 H), 1.06 (d, J = 6.7 Hz,
3 H), 0.87 (s, 9 H), 0.06 (s, 3 H), 0.04 (s, 3 H) ppm. ¹³C
NMR (125 MHz, CDCl3): δ = 157.4, 136.4,
128.5, 128.0, 127.8, 72.3, 67.3, 65.9, 65.6, 55.6, 41.4, 25.7, 18.0,
11.9, -4.8, -5.0 ppm. ESI-HRMS: m/z calcd
for C20H34NO4Si+ [M + H]+:
380.2252; found: 380.2264.
See Supporting Information.